🚨 New #HotTopic on the #BloodBrainBarrier ⏰! BBB endothelial cells keep strong circadian rhythms ex vivo, and these rhythms are pharmacologically tunable. 🔬 Sinensetin boosts BBB clock oscillations, while KL001 dampens them. 🔗 https://t.co/DkKAJ6FkOI #chronopharmacology

At #ISC26 catching an interesting RCT presentation on Chuanzhi Tongluo Capsule in acute ischemic stroke patients without LVO/MVO (CONCERN trial). @StrokeAHA_ASA

Neuroprotection journal was officially accepted for inclusion in the China Open Access Journal (COAJ) database. This marks yet another significant milestone in the journal's progress toward being indexed in authoritative databases.

Highlight of Day 2 at #ISC2026: Raghu Vemuganti is awarded the Thomas Willis Award for his work on RNAs in #stroke. Congrats Raghu. So well deserved.

Insightful talk by Anna Planas (IIBB-CSIC) on how innate immune responses differ across age #ISC26 @StrokeAHA_ASA

It is the final day of #ISC2026. Ongoing right now is a fantastic session on the #aging immune system and its implications for cerebrovascular disease and brain health

Talks underway at the ISC Invited Symposium on aging & the immune system in cerebrovascular disease. Moderated by Drs @LD_McCullough and David P. Sullivan — key discussion on how immune aging influences stroke risk and brain recovery. #ISC26 @StrokeAHA_ASA

Attending “Lessons from Neural Neuromodulation Stroke Motor Recovery Trials” at #ISC26, moderated by Drs. Wayne Feng, Teresa Kimberley, and Steven Cramer. @StrokeAHA_ASA

Really strong Digital Oral Poster Session this afternoon — rapid-fire science but high impact. #ISC26 From stem cell–mediated repair and tPA neuroprotection strategies to optogenetics–lipid metabolism links and single-cell insights into regeneration. @StrokeAHA_ASA

Prof. Yilong Wang presented a randomized, double-blind trial on tirofiban for branch atheromatous disease–related stroke — a challenging subtype where early progression remains a major issue. #ISC26 @StrokeAHA_ASA

#CHOICE-2 #IAT #alteplase following successful #EVT associated with better outcomes! #ISC26 @AHAScience @StrokeAHA_ASA @svinsociety @SVINJournal

Attending an excellent talk on super-late window reperfusion therapy by Yunyun Xiong from Beijing Tiantan Hospital at #ISC2026. Important discussion on expanding treatment windows and patient selection in late-presenting ischemic stroke. @StrokeAHA_ASA

Attending High Profile Clinical Trials: Reperfusion Therapy at #ISC26 — moderated by Prof. Yongjun Wang & Prof. Bijoy Menon 👏 Reperfusion science moving fast @StrokeAHA_ASA

@Chenhsbbb presenting his digital oral poster on blood-brain barrier disruption in hyperglycemic #stroke at #ISC2026. Very nice work! #BBB

Cell therapy for stroke is evolving — from early trials to smarter next-gen strategies. Exciting discussion on how to get it right at #ISC26 Moderated by Drs. Gary K. Steinberg & Cesar V. Borlongan. @StrokeAHA_ASA

Moderated by Joanna M Wardlaw (University of Edinburgh) & Mark Fisher (University of California Irvine) Session on red blood cells & stroke pathogenesis at International Stroke Conference 🩸🧠 RBC biology is getting the attention it deserves. #ISC26 @StrokeAHA_ASA

At International Stroke Conference today! 🕔 5:48 PM 📍 Digital Oral Poster Theater 5 Come by if you’re around — would love to say hi and talk stroke science 🧠✨ #ISC26 @StrokeAHA_ASA

Welcome from AHA leadership, Presidential Address, Feinberg Award Lecture, and major clinical trial updates — an exciting start to the meeting. Led by Lauren H Sansing #ISC26 @StrokeAHA_ASA

Attending a presentation on brain cell-type–specific vulnerabilities following hemorrhage by Marietta Zille (University of Vienna). #ISC26 Focused discussion on differential cellular responses and implications for targeted therapeutic strategies. @StrokeAHA_ASA

Sitting in on a talk about targeting the hemostatic cascade in ICH by Kunjan R Dave. #ISC26 Nice overview of the potential of RMP in ICH therapies. @StrokeAHA_ASA